StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Nuvation Bio's market cap was $1.49B on Nov 11, 2026, against $2.71B a year earlier. Over the last 5 years it ranged from $210.93M to $3.03B, with a median of $760.14M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.49B-50.9%
2025Dec 31, 2025$3.03B+238.4%
2024Dec 31, 2024$894.42M+170.5%
2023Dec 29, 2023$330.61M-21.2%
2022Dec 30, 2022$419.31M-77.3%
2021Dec 31, 2021$1.85B–

More Nuvation Bio figures

See a number that looks wrong?